T vs XBIO · P/E 7.4, rev $63.06B vs rev $1.5M
AT&T Inc. (T) versus Xenetic Biosciences Inc (XBIO) — a side-by-side from cached financials, not a winner call.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
Xenetic Biosciences Inc (XBIO) is a biotechnology company listed on US.
Latest reported T revenue for 2026-06-30 was $63.06B. Net income was $8.46B. T currently screens at market cap $155.92B and trailing P/E 7.4.
Latest reported XBIO revenue for 2026-06-30 was $1.5M. Net income was -$1.4M. Revenue was up 81.9% from 2026-03-31 to 2026-06-30. XBIO currently screens at market cap $5.7M.
T currently screens at market cap $155.92B and trailing P/E 7.4. XBIO currently screens at market cap $5.7M.
Not investment advice. Open the T and XBIO stock pages for the full models.
Not investment advice.